Capio Biosciences
Biotechnology, 505 S Rosa Rd, Madison, Wisconsin, 53719, United States, 1-10 Employees
Phone Number: +16*********
Who is CAPIO BIOSCIENCES
Our Vision: To be the worlds leading liquid biopsy company providing valuable clinical information to improve patient outcomes. Founded in 2015 by cofounders Seungpyo Hong PhD (UW, Madiso...
Read More
-
Headquarters: 505 S Rosa Rd, Madison, Wisconsin, 53719, United States
-
Date Founded: 2015
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 6799
Does something look wrong? Fix it. | View contact records from CAPIO BIOSCIENCES
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Capio Biosciences
Answer: Capio Biosciences's headquarters are located at 505 S Rosa Rd, Madison, Wisconsin, 53719, United States
Answer: Capio Biosciences's phone number is +16*********
Answer: Capio Biosciences's official website is https://capiobiosciences.com
Answer: Capio Biosciences's revenue is $1 Million to $5 Million
Answer: Capio Biosciences's SIC: 6799
Answer: Capio Biosciences has 1-10 employees
Answer: Capio Biosciences is in Biotechnology
Answer: Capio Biosciences contact info: Phone number: +16********* Website: https://capiobiosciences.com
Answer: Our Vision: To be the worlds leading liquid biopsy company providing valuable clinical information to improve patient outcomes. Founded in 2015 by cofounders Seungpyo Hong PhD (UW, Madison WI) and Andrew Wang MD (UNC, Chapel Hill NC), Capio Biosciences is a biotech start-up focused on delivering high-value oncology diagnostics that can help inform patient care decisions and improve outcomes. At Capio Biosciences we are currently developing an advanced platform called CapioCyteTM for the capture of circulating tumor cells (CTCs) from whole blood. By utilizing a combination of biomimetic cell rolling and dendrimer-mediated multivalent cell capture, CapioCyte delivers significantly greater capture sensitivity than other platforms currently available. It is also able to provide enriched CTCs for post capture molecular analysis such as FISH, RNA-Seq and NGS. CapioCyte is therefore an excellent tool for todays cancer research needs, and potentially for clinical patient management in the future.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month